Corrigendum to ‘Teriparatide ameliorates articular cartilage degradation and aberrant subchondral bone remodeling in DMM mice’ [J. Orthop. Transl.] 38 (2023) 241–255]

The authors regret “an error occurred in the Fig. S3. PTH (1-34) attunes the KOA progression by restoring cartilage thickness and retaining GAG content from (a) Alican Blue staining and (b) Masson staining.” in Appendix A. Supplementary data in our published paper. We found an error of DMM OPG^-/- mice at the 8^th week and the 12th week in Alican Blue staining. We now have corrected the Fig. S3 and used the right histology evaluation (DMM OPG^-/- mice at the 12th week). Of note that, the correction of the Fig. S3 would have no influence on the conclusion of the current study.

The authors would like to apologise for any inconvenience caused.

Here is the original published one (Fig. 1) for Appendix A. Supplementary data Fig. S3. An error occurred in the DMM OPG^-/- mice at the 8th week and the 12th week.

Fig. 1 The original published one for Appendix A. Supplementary data Fig. S3.

Fig. 2 The amended figure for Appendix A. Supplementary data Fig. S3.

Here is the amended figure (Fig. 2) for Appendix A. Supplementary data Fig. S3. We used the corrected histology evaluation (DMM OPG^-/- mice at the 12^th week) in Alican Blue staining.